Isoeugenol
WikiDoc Resources for Isoeugenol |
Articles |
---|
Most recent articles on Isoeugenol |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Isoeugenol at Clinical Trials.gov Clinical Trials on Isoeugenol at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Isoeugenol
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Isoeugenol Discussion groups on Isoeugenol Patient Handouts on Isoeugenol Directions to Hospitals Treating Isoeugenol Risk calculators and risk factors for Isoeugenol
|
Healthcare Provider Resources |
Causes & Risk Factors for Isoeugenol |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Isoeugenol is a phenylpropene, a propenyl-substituted guaiacol. A phenylpropanoid, it occurs in the essential oils of plants such as ylang-ylang (Cananga odorata). It can be synthesized from eugenol and had been used in the manufacture of vanillin. It may occur as either the cis (Z) or trans (E) isomer. Trans (E) isoeugenol is crystalline while cis (Z) isoeugenol is a liquid.[citation needed]
References
- The Merck Index, 12th edition, Merck & Co, Whitehouse Station, New Jersey, USA, 1996.